ALTO-101 Receives FDA Fast Track Designation for Treatment of Cognitive Impairment ...

Retrieved on: 2025-10-03 18:27:04

Tags for this article:

Click the tags to see associated articles and topics

ALTO-101 Receives FDA Fast Track Designation for Treatment of Cognitive Impairment .... View article details on hiswai:

Excerpt

Alto Neuroscience reported significant and clinically relevant effects of ALTO-101 as measured by both electroencephalogram (EEG) and cognitive ...

Article found on: www.psychiatrictimes.com